SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 88,400
-700 (-0.79%)
At close: Jun 2, 2026
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 6.92 trillion as of June 3, 2026. Its market cap has decreased by -10.71% in one year.
Market Cap
6.92T
Enterprise Value
6.66T
Revenue
790.25B
Ranking
n/a
PE Ratio
19.85
Stock Price
88,400.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 6.92T, a decrease of -30.39%. That is a compound annual growth rate of -5.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 6.92T | -29.05% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Epis Holdings | 11.55T |
| Kolon TissueGene | 9.15T |
| HLB Co., Ltd. | 6.92T |
| Peptron | 6.31T |
| LigaChem Biosciences | 5.44T |
| Voronoi | 4.19T |
| D&D Pharmatech | 3.68T |
| SK bioscience | 3.24T |